CereSpir
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
41 Madison Ave Fl 31, New York City, New...Phone Number
(646) 202-2562Website
www.cerespir.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CereSpir
CereSpir Inc. is focused on the innovative field of immuno-neurology, developing treatments for Parkinson's disease and other neurodegenerative conditions. The company is advancing Itanapraced, the most developed therapeutic agent targeting LRRK2 neurotoxicity and the only AICD inhibitor currently in development. CereSpir aims to address the challenges posed by neurodegeneration through its unique therapeutic approaches. Their intended clients include patients suffering from neurodegenerative diseases and the medical community involved in neurology.Explore more
CereSpir Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CereSpir your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CereSpir, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CereSpir has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CereSpir
Click to see if CereSpir had a recent Job posting/layoffs
Check out if CereSpir is spiking on competitors!
Product Launch: Get notified when CereSpir launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on CereSpir recently announced quarterly report
Funding: Get notified immidiatlly once CereSpir has new funding data
Recommended Actions
Reach out to Masked Content who joined CereSpir as Masked Content
Find 2 more new buyers
Compare Similar Companies to CereSpir
Compare insights from companies similar to CereSpir, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CereSpir is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CereSpir is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CereSpir.
CereSpir financials insights
Gather financial insights about CereSpir, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$500K
CereSpir Tech Stack
A closer look at the technologies used by CereSpir
See more technologies
CereSpir News & Media
CERESPIR INCORPORATED Assembles World Class Clinical Advisory Board Chaired by Professor Robert A. Hauser to Support CERESPIR's Parkinson's Disease Development Program for Itanapraced
NEW YORK, March 26, 2019 /PRNewswire/ -- CERESPIR INCORPORATED, a pharmaceutical company fortunate in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, announced the formation of an expanded Clinical Advisory Board (CAB) to...CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease
NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research and education, announced today that they have obtained animal proof of con
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CereSpir
Sign Up For FreeTo access detailed company insights
CereSpir Inc. is focused on the innovative field of immuno-neurology, developing treatments for Parkinson's disease and other neurodegenerative conditions. The company is advancing Itanapraced, the most developed therapeutic agent targeting LRRK2 neurotoxicity and the only AICD inhibitor currently in development. CereSpir aims to address the challe... Read More
